BRAKE v. SINGH - Page 55




                Interference 102,728                                                                                                          
                plasmid p60?34  Burroughs Wellcome Co. v. Barr Laboratories, Inc., 40 F.3d at 1229,                                           
                32 USPQ2d at 1921; Oka v. Youssefyeh, 849 F.2d at 581, 7 USPQ2d at 1171.                                                      
                                 1.      Dr. Singh’s testimony with respect to his “plan”                                                     
                         Singh relies on Dr. Singh’s testimony (SR 564, paras. 47 and 50 of his                                               
                declaration), wherein he states [emphasis added]:                                                                             
                                 47.     On December 1, 1982, I prepared a synthetic DNA request for a                                        
                         24mer.  This oligonucleotide was to be used for making the inframe deletion of                                       
                         the junction of "-factor pro sequence and interferon instead of the                                                  
                         oligonucleotide discussed at paragraph 45.  The 24mer requested was                                                  
                         AGGGAGATCACATCTTTTATCCAA.  A copy of this Synthetic DNA Request as                                                   
                         well as a Synthetic DNA Specification form is shown at Notebook 1249, page 77                                        
                         (Singh Exhibit 3, Bates No. 000126).  As indicated on the Synthetic DNA                                              
                         Specifications, the purification of this 24mer was completed on December 20,                                         
                         1982.  (Singh Exhibit 3, Notebook 1249, Bates No. 000126).                                                           

                And,                                                                                                                          
                                 50.     On December 14, 1982 I presented my results to the Research                                          
                         Review Group (RRG).  Yeast secretion was discussed by myself and Ronald                                              
                         Hitzeman.  Singh Exhibit 25 (Bates Nos. 000455-000487) includes a summary of                                         
                         the meeting and the documents I presented at the Meeting.  In this Exhibit all but                                   
                         the pertinent information has been blocked out.  At this meeting I described the                                     
                         "-factor gene organization and its structure including the spacer having the                                         
                         sequence lys arg followed by glu ala’s.  I also described that my future work                                        
                         would include removal of sequences from the interferon D expression plasmid                                          
                         with site directed deletion mutagenesis and construction of expression plasmids                                      
                         with a restriction site following the "-factor prepro sequence.  (Singh Exhibit 25,                                  
                         Bates Nos. 000455-000487).                                                                                           





                         34 p60 is a yeast plasmid which comprises a nucleotide sequence which                                                
                encodes, 5N6 3N, the " factor leader, the " factor spacer sequence (lys-arg-glu-ala-glu-                                      
                ala), the amino acids leu, glu, phe, met, and interferon D (IFN-D).                                                           
                                                                     55                                                                       





Page:  Previous  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  Next 

Last modified: November 3, 2007